Efficacy, safety, and tolerability of remibrutinib (LOU064) in CSU patients: Study design of phase 3B extension trial

被引：0
|
作者：
Maurer, M. [1 ,2 ,3 ,4 ]
Gimenez-Arnau, A. M. [5 ]
Saini, S. [6 ]
Lebwohl, M. [7 ]
Sussman, G. [8 ]
Hide, M. [9 ,10 ]
Lheritier, K. [11 ]
Zharkov, A. [11 ]
Bhat, S. [12 ]
Wei, L. [13 ]
Martzloff, E. D. [11 ]
Haemmerle, S. [11 ]
机构：
[1] UCARE, Inst Allergol, Berlin, Germany
[2] Freie Univ, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Fraunhofer Inst Translat Med & Pharmacol ITMP, Berlin, Germany
[5] Univ Pompeu Fabra, Hosp Mar IMIM, Dept Dermatol, Barcelona, Spain
[6] Johns Hopkins Univ, Div Allergy & Clin Immunol, Sch Med, Baltimore, MD USA
[7] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[8] Univ Toronto, Div Allergy & Clin Immunol, Toronto, ON, Canada
[9] Hiroshima Univ, Dept Dermatol, Hiroshima, Japan
[10] Hiroshima Citizens Hosp, Dept Dermatol, Hiroshima, Japan
[11] Novartis Pharma AG, Basel, Switzerland
[12] Novartis Healthcare Pvt Ltd, Hyderabad, India
[13] China Novartis Inst Biomed Res Co Ltd, Shanghai, Peoples R China
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000937
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of daclizumab beta in patients with relapsing-remitting MS switching from natalizumab: rationale and study design of the phase 3b SUSTAIN study
    Giovannoni, G.
    Bhan, V.
    Centonze, D.
    Cohan, S.
    Ziemssen, T.
    Easter, J.
    Chiodo, L.
    Jiang, X.
    Fam, S.
    Giannattasio, G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 867 - 868
  • [22] A phase 3 open-label extension study of the efficacy and safety of lanadelumab for the prevention of angioedema attacks in patients with hereditary angioedema: trial design
    Riedl, M.
    Bernstein, J. A.
    Craig, T.
    Banerji, A.
    Magerl, M.
    Cicardi, M.
    Longhurst, H. J.
    Shennak, M.
    Yang, W.
    Schranz, J.
    Baptista, J.
    Busse, P.
    ALLERGY, 2017, 72 : 598 - 599
  • [23] Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial
    Gregory N. Beatch
    Brian Mangal
    BMC Cardiovascular Disorders, 16
  • [24] Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial
    Beatch, Gregory N.
    Mangal, Brian
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [25] A Phase 3b Trial to Evaluate the Efficacy and Safety of Gefapixant in Adults with Recent-Onset Chronic Cough
    Mcgarvey, L.
    Sher, M. R.
    Afzal, A. Sadaf
    La Rosa, C.
    Muccino, D.
    Nguyen, A. Martin
    Schelfhout, J.
    Wu, W.
    Xu, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] Maintenance of efficacy, safety and tolerability of ponesimod in patients with relapsing remitting multiple sclerosis: phase II extension study
    Pozzilli, C.
    Fernandez, O.
    Olsson, T.
    Freedman, M. S.
    Melanson, M.
    Boster, A.
    Radue, E-W
    Hennessy, B.
    Rames, A.
    D'Ambrosio, D.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 456 - 457
  • [27] Garadacimab for hereditary angioedema prophylaxis in adolescents: efficacy and safety from the VANGUARD Phase 3 and 3b open-label extension trial (first interim analysis)
    Magerl, M.
    Saguer, I. Martinez
    Jacos, J. S.
    Li, H.
    Bernstein, J. A.
    Hsu, C.
    Sitz, K. V.
    Pragst, I.
    Feuersenger, H.
    Wieman, L.
    Pollen, M.
    Rese, A.
    ALLERGOLOGIE, 2023, 46 (08) : 562 - 562
  • [28] Effectiveness and Tolerability of Ofatumumab Versus First-line DMTs in Early RMS Patients: Phase 3b STHENOS Study Design
    Montalban, X.
    Linker, R.
    Centonze, D.
    Turner, B.
    Sanchez-de la Rosa, R.
    Nillos, L.
    Ettle, B.
    Raponi, E.
    Thouvenot, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 357 - 358
  • [29] Bimekizumab efficacy and safety through 96 weeks in patients with moderate to severe plaque psoriasis: Results from the open-label extension period of the BE RADIANT phase 3b trial
    Strober, Bruce
    Paul, Carle
    Blauvelt, Andrew
    Thaci, Diamant
    Elewski, Boni
    White, Katy
    Vanvoorden, Veerle
    Deherder, Delphine
    Staelens, Fabienne
    Spelman, Lynda
    Eyerich, Kilian
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 14 - 14
  • [30] Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)
    Griesshammer, Martin
    Vannucchi, Alessandro M.
    le Coutre, Philipp
    Tavares, Renato S.
    Al-Ali, Haifa Kathrin
    Raanani, Pia
    Gupta, Vikas
    Foltz, Lynda M.
    Giraldo, Pilar
    Bouard, Catherine
    Ronco, Julian Perez
    Ghosh, Jagannath
    Martino, Bruno
    BLOOD, 2014, 124 (21)
12345